ABRILADA

ADALIMUMAB-AFZB · Pfizer Laboratories Div Pfizer Inc

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ABRILADA, covering 2019-11-15 to 2025-12-17. Get the full timeline:

Most recent: FDA Approved: ABRILADA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)